Research Archive — Page 78 of 133
-
November 18, 2020
Why does COVID-19 seem to spare children? Vanderbilt University Medical Center study offers an answer
Researchers at Vanderbilt University Medical Center (VUMC) and their colleagues have determined a key factor as to why COVID-19 appears to infect and sicken adults and older people preferentially while seeming to spare younger children. -
November 18, 2020
New drug for metastatic colorectal cancer enters phase 3 trial
A new therapy for metastatic colorectal cancer that has been granted fast track designation by the U.S. Food and Drug Administration is being tested in a phase 3 clinical trial at Vanderbilt-Ingram Cancer Center. -
November 17, 2020
Statins to be studied for prevention of dementia, disability and heart disease
Vanderbilt University Medical Center researchers are enrolling adults aged 75 and over to study whether taking atorvastatin, a drug commonly used to lower cholesterol also called Lipitor®, can help maintain health by preventing dementia, disability, and heart disease. -
November 17, 2020
A cohort for type 2 diabetes studies
A study group of more than 600,000 patients with type 2 diabetes, identified from electronic medical records in the PCORnet national research network, could be valuable for assessing the safety of type 2 diabetes drugs. -
November 16, 2020
Younger parents less likely to vaccinate their children and themselves against COVID-19
Younger parents were much less likely than older parents to say they planned to vaccinate their children and themselves against COVID-19. -
November 16, 2020
Imaging “biomarker” for Alzheimer’s disease progression
Changes in connectivity in the brain’s white matter may be a novel neuroimaging biomarker for assessing Alzheimer’s disease progression. -
November 12, 2020
New therapeutic target for lung cancer
Vanderbilt researchers have identified a new molecular partner — and potential therapeutic target — in a signaling axis that drives lung cancer.